Qube Research & Technologies Ltd - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 1 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$5,770,042
+2264.8%
385,956
+1203.5%
0.03%
+3000.0%
Q3 2022$244,000
+98.4%
29,609
+57.9%
0.00%0.0%
Q2 2022$123,000
+4.2%
18,750
+4.6%
0.00%0.0%
Q2 2021$118,00017,9280.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,986,176$12,275,0002.58%
Worth Venture Partners, LLC 454,364$2,808,0001.26%
Opaleye Management Inc. 455,600$2,816,0000.53%
J. Goldman & Co LP 1,663,229$10,279,0000.52%
X-Square Capital, LLC 92,283$570,0000.30%
NEA Management Company, LLC 3,952,958$24,429,0000.29%
Birchview Capital, LP 40,000$247,0000.17%
PERSONAL CFO SOLUTIONS, LLC 23,000$142,0000.03%
PURA VIDA INVESTMENTS, LLC 147,574$912,0000.03%
GSA CAPITAL PARTNERS LLP 35,232$218,0000.02%
View complete list of AVEO PHARMACEUTICALS INC shareholders